Cargando…
肿瘤靶向治疗和免疫治疗——眼科系统毒性反应的诊治
The increasing use of target therapy and immunocheckpoint inhibitors in cancers has brought new hope of survival to patients with advanced tumors. However, more and more adverse side-effects and toxicities of these medications had been reported, affect almost all human organs including the eye. Thes...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
中国肺癌杂志编辑部
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6817431/ https://www.ncbi.nlm.nih.gov/pubmed/31650949 http://dx.doi.org/10.3779/j.issn.1009-3419.2019.10.09 |
_version_ | 1783463417706708992 |
---|---|
collection | PubMed |
description | The increasing use of target therapy and immunocheckpoint inhibitors in cancers has brought new hope of survival to patients with advanced tumors. However, more and more adverse side-effects and toxicities of these medications had been reported, affect almost all human organs including the eye. These adverse effects may affect the entire ocular tissues, like eyelid, eye lashes, conjunctiva, cornea, uvea, retina, optic nerve and so on, which are always been ignored by patients and doctors. In this paper we will summarize the characteristics of the related ocular diseases and give our advice on how to diagnose and manage these diseases. |
format | Online Article Text |
id | pubmed-6817431 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | 中国肺癌杂志编辑部 |
record_format | MEDLINE/PubMed |
spelling | pubmed-68174312019-11-12 肿瘤靶向治疗和免疫治疗——眼科系统毒性反应的诊治 Zhongguo Fei Ai Za Zhi 免疫检查点抑制剂专题 The increasing use of target therapy and immunocheckpoint inhibitors in cancers has brought new hope of survival to patients with advanced tumors. However, more and more adverse side-effects and toxicities of these medications had been reported, affect almost all human organs including the eye. These adverse effects may affect the entire ocular tissues, like eyelid, eye lashes, conjunctiva, cornea, uvea, retina, optic nerve and so on, which are always been ignored by patients and doctors. In this paper we will summarize the characteristics of the related ocular diseases and give our advice on how to diagnose and manage these diseases. 中国肺癌杂志编辑部 2019-10-20 /pmc/articles/PMC6817431/ /pubmed/31650949 http://dx.doi.org/10.3779/j.issn.1009-3419.2019.10.09 Text en 版权所有©《中国肺癌杂志》编辑部2019 https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 3.0) License. See: https://creativecommons.org/licenses/by/3.0/ |
spellingShingle | 免疫检查点抑制剂专题 肿瘤靶向治疗和免疫治疗——眼科系统毒性反应的诊治 |
title | 肿瘤靶向治疗和免疫治疗——眼科系统毒性反应的诊治 |
title_full | 肿瘤靶向治疗和免疫治疗——眼科系统毒性反应的诊治 |
title_fullStr | 肿瘤靶向治疗和免疫治疗——眼科系统毒性反应的诊治 |
title_full_unstemmed | 肿瘤靶向治疗和免疫治疗——眼科系统毒性反应的诊治 |
title_short | 肿瘤靶向治疗和免疫治疗——眼科系统毒性反应的诊治 |
title_sort | 肿瘤靶向治疗和免疫治疗——眼科系统毒性反应的诊治 |
topic | 免疫检查点抑制剂专题 |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6817431/ https://www.ncbi.nlm.nih.gov/pubmed/31650949 http://dx.doi.org/10.3779/j.issn.1009-3419.2019.10.09 |
work_keys_str_mv | AT zhǒngliúbǎxiàngzhìliáohémiǎnyìzhìliáoyǎnkēxìtǒngdúxìngfǎnyīngdezhěnzhì AT zhǒngliúbǎxiàngzhìliáohémiǎnyìzhìliáoyǎnkēxìtǒngdúxìngfǎnyīngdezhěnzhì AT zhǒngliúbǎxiàngzhìliáohémiǎnyìzhìliáoyǎnkēxìtǒngdúxìngfǎnyīngdezhěnzhì AT zhǒngliúbǎxiàngzhìliáohémiǎnyìzhìliáoyǎnkēxìtǒngdúxìngfǎnyīngdezhěnzhì AT zhǒngliúbǎxiàngzhìliáohémiǎnyìzhìliáoyǎnkēxìtǒngdúxìngfǎnyīngdezhěnzhì AT zhǒngliúbǎxiàngzhìliáohémiǎnyìzhìliáoyǎnkēxìtǒngdúxìngfǎnyīngdezhěnzhì AT zhǒngliúbǎxiàngzhìliáohémiǎnyìzhìliáoyǎnkēxìtǒngdúxìngfǎnyīngdezhěnzhì AT zhǒngliúbǎxiàngzhìliáohémiǎnyìzhìliáoyǎnkēxìtǒngdúxìngfǎnyīngdezhěnzhì AT zhǒngliúbǎxiàngzhìliáohémiǎnyìzhìliáoyǎnkēxìtǒngdúxìngfǎnyīngdezhěnzhì AT zhǒngliúbǎxiàngzhìliáohémiǎnyìzhìliáoyǎnkēxìtǒngdúxìngfǎnyīngdezhěnzhì AT zhǒngliúbǎxiàngzhìliáohémiǎnyìzhìliáoyǎnkēxìtǒngdúxìngfǎnyīngdezhěnzhì AT zhǒngliúbǎxiàngzhìliáohémiǎnyìzhìliáoyǎnkēxìtǒngdúxìngfǎnyīngdezhěnzhì AT zhǒngliúbǎxiàngzhìliáohémiǎnyìzhìliáoyǎnkēxìtǒngdúxìngfǎnyīngdezhěnzhì AT zhǒngliúbǎxiàngzhìliáohémiǎnyìzhìliáoyǎnkēxìtǒngdúxìngfǎnyīngdezhěnzhì |